MicrobiologybioRxivPreprint
HIV-1 resistance to islatravir/tenofovir combination therapy in wild-type or NRTI resistant strains of diverse HIV-1 subtypes
M. A. Cilento, X. Wen, A. B. Reeve…·S. G. Sarafianos
This study evaluates resistance to islatravir and tenofovir in HIV-1 strains with mutations K65R, M184V, and S68G/N, showing that their combination has a high genetic barrier to resistance.
DOI 10.1101/2023.06.18.545484